19.79

6.63% 1.23

Integra Lifesciences Holdings Corp (IART)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Integra Lifesciences Holdings Corp stock is traded at $19.79, with a volume of 901.08K. It is up +6.63% in the last 24 hours and up +11.30% over the past month. Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Previous Close:

$18.56

Open:

$18.75

24h Volume:

901.08K

Relative Volume:

0.89

Market Cap:

$1.54B

Revenue:

$1.64B

Net Income/Loss:

$-495.80M

P/E Ratio:

-3.0903

EPS:

-6.404

Net Cash Flow:

$-45.25M

1W Performance:

+2.81%

1M Performance:

+11.30%

6M Performance:

+66.30%

1Y Performance:

+55.70%

1-Day Range:

$18.56

$19.84

1-Week Range:

$18.29

$19.84

52-Week Range:

$8.70

$20.26

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Name

Integra Lifesciences Holdings Corp

Sector

Healthcare (1071)

Industry

Medical Devices (140)

Phone

(609) 275-0500

Address

1100 CAMPUS ROAD, PRINCETON, NJ

Employee

4,427

Twitter

@integra_life

Next Earnings Date

2026-07-29

Latest SEC Filings

IART's Discussions on Twitter

Compare IART vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IART Integra Lifesciences Holdings Corp	19.79	1.54B	1.64B	-495.80M	-45.25M	-6.404
ABT Abbott Laboratories	103.06	179.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.25	126.60B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.21	106.51B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	44.25	65.77B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	82.63	47.58B	6.30B	1.07B	1.09B	1.8406

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Downgrade	Argus	Buy → Hold
Mar-31-25	Upgrade	Argus	Hold → Buy
Dec-02-24	Initiated	Morgan Stanley	Underweight
Oct-07-24	Upgrade	BTIG Research	Sell → Neutral
Jul-30-24	Downgrade	BTIG Research	Neutral → Sell
Jul-30-24	Downgrade	Citigroup	Neutral → Sell
May-07-24	Downgrade	Oppenheimer	Outperform → Perform
May-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-03-24	Upgrade	Citigroup	Sell → Neutral
Dec-05-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Nov-14-23	Initiated	CL King	Buy
Aug-24-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jul-12-23	Upgrade	Jefferies	Hold → Buy
Jun-08-23	Downgrade	Argus	Buy → Hold
May-24-23	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Downgrade	Citigroup	Neutral → Sell
Oct-12-22	Initiated	Jefferies	Hold
Jul-25-22	Initiated	Morgan Stanley	Equal-Weight
Apr-13-22	Downgrade	Truist	Buy → Hold
Dec-17-21	Upgrade	JP Morgan	Underweight → Neutral
Sep-15-21	Downgrade	BTIG Research	Buy → Neutral
Oct-08-20	Downgrade	JP Morgan	Neutral → Underweight
May-27-20	Initiated	Citigroup	Neutral
Apr-03-20	Initiated	SunTrust	Buy
Jan-07-20	Downgrade	Piper Jaffray	Overweight → Neutral
Jan-07-20	Downgrade	Piper Sandler	Overweight → Neutral
Jan-03-19	Initiated	SunTrust	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-07-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-18	Upgrade	BTIG Research	Neutral → Buy
Jul-02-18	Downgrade	Citigroup	Buy → Neutral
Jan-05-18	Resumed	Cantor Fitzgerald	Neutral
Jan-02-18	Downgrade	BofA/Merrill	Buy → Neutral
Nov-09-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-30-17	Downgrade	Wells Fargo	Outperform → Market Perform
Oct-27-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-30-17	Initiated	Cantor Fitzgerald	Overweight
May-02-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-13-17	Reiterated	RBC Capital Mkts	Sector Perform
Jan-06-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Dec-12-16	Initiated	UBS	Buy

View All

Integra Lifesciences Holdings Corp Stock (IART) Latest News

Jul 24, 2026

Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 24, 2026

Jul 23, 2026

Kaskela Law Firm Announces Investigation of Integra LifeSciences - GuruFocus

Jul 23, 2026

IART|Integra Lifesciences Holdings Corp|Price:19.790|Chg%:+1.230 - TradingKey

Jul 23, 2026

Jul 18, 2026

How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story - Yahoo Finance

Jul 18, 2026

Jul 17, 2026

A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% D - GuruFocus

Jul 17, 2026

Integra LifeSciences Holdings (IART) Stock Still Looks Below Fair Value Following A 70% Five Year Fall - Yahoo Finance

Jul 17, 2026

Jul 16, 2026

Integra LifeSciences to announce Q2 2026 results on July 29 - scanx.trade

Jul 16, 2026

Integra LifeSciences Holdings Corporation (IART) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Jul 16, 2026

Integra LifeSciences to Release Results Before Market Open July 29 - Stock Titan

Jul 16, 2026

Jul 15, 2026

Integra LifeSciences stock hits 52-week high at 18.93 USD - Investing.com

Jul 15, 2026

Jul 12, 2026

ETFs Investing in Integra LifeSciences Holdings Corporation Stocks - TradingView

Jul 12, 2026

Jul 09, 2026

IART Initiated Coverage by BMO Capital -- Rating Set to Market P - GuruFocus

Jul 09, 2026

BMO initiates Integra LifeSciences stock at Market Perform By Investing.com - Investing.com India

Jul 09, 2026

Form 4 Integra LifeSciences Holdings For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026

Integra Lifesciences (NASDAQ: IART) SVP uses 937 shares for tax withholding - Stock Titan

Jul 06, 2026

Integra LifeSciences (IART) grants EVP 5,590 RSUs vesting over 3 years - Stock Titan

Jul 06, 2026

Integra LifeSciences (IART) EVP awarded 11,180 RSUs in new equity grant - Stock Titan

Jul 06, 2026

IART CFO Lea Daniels Knight uses 5,226 shares to satisfy tax obligations - Stock Titan

Jul 06, 2026

Jul 03, 2026